Cargando…

The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia

INTRODUCTION: Noninvasive risk assessment is crucial in patients with COVID-19 in emergency department. Since limited data is known about the role of noninvasive parameters, we aimed to evaluate the role of a noninvasive parameter ‘SpO2/FiO2’ in independently predicting 30-day mortality in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Satici, Merve Osoydan, Islam, Mehmet Muzaffer, Satici, Celal, Uygun, Cemre Nur, Ademoglu, Enis, Altunok, İbrahim, Aksel, Gokhan, Eroglu, Serkan Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044731/
https://www.ncbi.nlm.nih.gov/pubmed/35525158
http://dx.doi.org/10.1016/j.ajem.2022.04.036
_version_ 1784695166988189696
author Satici, Merve Osoydan
Islam, Mehmet Muzaffer
Satici, Celal
Uygun, Cemre Nur
Ademoglu, Enis
Altunok, İbrahim
Aksel, Gokhan
Eroglu, Serkan Emre
author_facet Satici, Merve Osoydan
Islam, Mehmet Muzaffer
Satici, Celal
Uygun, Cemre Nur
Ademoglu, Enis
Altunok, İbrahim
Aksel, Gokhan
Eroglu, Serkan Emre
author_sort Satici, Merve Osoydan
collection PubMed
description INTRODUCTION: Noninvasive risk assessment is crucial in patients with COVID-19 in emergency department. Since limited data is known about the role of noninvasive parameters, we aimed to evaluate the role of a noninvasive parameter ‘SpO2/FiO2’ in independently predicting 30-day mortality in patients with COVID-19 and its prognostic utility in combination with a noninvasive score ‘CRB-65’. METHODS: A retrospective study was performed in a tertiary training and research hospital, which included 272 patients with COVID-19 pneumonia diagnosed with polymerase chain reaction in emergency department. Data on characteristics, vital signs, and laboratory parameters were recorded from electronic medical records. The primary outcome of the study was 30-day mortality, and we assessed the discriminative ability of SpO2/FiO2 in predicting mortality in patients with COVID-19 pneumonia and its prognostic utility in combination with conventional pneumonia risk assessment scores. RESULTS: Multivariate analysis revealed that only SpO2/FiO2 level was found to be an independent parameter associated with 30-day mortality (OR:0.98, 95% CI: 0.98–0.99, p = 0.003). PSI and CURB-65 were found to be better scores than CRB-65 in predicting 30-day mortality (AUC: 0.79 vs 0.72, p = 0.04; AUC: 0.76 vs 0.72, p = 0.01 respectively). Both SpO2/FiO2 combined with CRB-65 and SpO2/FiO2 combined with CURB-65 have good discriminative ability and seemed to be more favorable than PSI in predicting 30-days mortality (AUC: 0.83 vs 0.75; AUC: 0.84 vs 0.75), however no significant difference was found (p = 0.21 and p = 0.06, respectively). CONCLUSION: SpO2/FiO2 is a promising index in predicting mortality. Addition of SpO2/FiO2 to CRB-65 improved the role of CRB-65 alone, however it performed similar to PSI. The combined noninvasive model of SpO2/FiO2 and CRB-65 may help physicians quickly stratify COVID-19 patients on admission, which is expected to be particularly important in hospitals still stressed by pandemic volumes.
format Online
Article
Text
id pubmed-9044731
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-90447312022-04-28 The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia Satici, Merve Osoydan Islam, Mehmet Muzaffer Satici, Celal Uygun, Cemre Nur Ademoglu, Enis Altunok, İbrahim Aksel, Gokhan Eroglu, Serkan Emre Am J Emerg Med Article INTRODUCTION: Noninvasive risk assessment is crucial in patients with COVID-19 in emergency department. Since limited data is known about the role of noninvasive parameters, we aimed to evaluate the role of a noninvasive parameter ‘SpO2/FiO2’ in independently predicting 30-day mortality in patients with COVID-19 and its prognostic utility in combination with a noninvasive score ‘CRB-65’. METHODS: A retrospective study was performed in a tertiary training and research hospital, which included 272 patients with COVID-19 pneumonia diagnosed with polymerase chain reaction in emergency department. Data on characteristics, vital signs, and laboratory parameters were recorded from electronic medical records. The primary outcome of the study was 30-day mortality, and we assessed the discriminative ability of SpO2/FiO2 in predicting mortality in patients with COVID-19 pneumonia and its prognostic utility in combination with conventional pneumonia risk assessment scores. RESULTS: Multivariate analysis revealed that only SpO2/FiO2 level was found to be an independent parameter associated with 30-day mortality (OR:0.98, 95% CI: 0.98–0.99, p = 0.003). PSI and CURB-65 were found to be better scores than CRB-65 in predicting 30-day mortality (AUC: 0.79 vs 0.72, p = 0.04; AUC: 0.76 vs 0.72, p = 0.01 respectively). Both SpO2/FiO2 combined with CRB-65 and SpO2/FiO2 combined with CURB-65 have good discriminative ability and seemed to be more favorable than PSI in predicting 30-days mortality (AUC: 0.83 vs 0.75; AUC: 0.84 vs 0.75), however no significant difference was found (p = 0.21 and p = 0.06, respectively). CONCLUSION: SpO2/FiO2 is a promising index in predicting mortality. Addition of SpO2/FiO2 to CRB-65 improved the role of CRB-65 alone, however it performed similar to PSI. The combined noninvasive model of SpO2/FiO2 and CRB-65 may help physicians quickly stratify COVID-19 patients on admission, which is expected to be particularly important in hospitals still stressed by pandemic volumes. Elsevier Inc. 2022-07 2022-04-27 /pmc/articles/PMC9044731/ /pubmed/35525158 http://dx.doi.org/10.1016/j.ajem.2022.04.036 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Satici, Merve Osoydan
Islam, Mehmet Muzaffer
Satici, Celal
Uygun, Cemre Nur
Ademoglu, Enis
Altunok, İbrahim
Aksel, Gokhan
Eroglu, Serkan Emre
The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia
title The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia
title_full The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia
title_fullStr The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia
title_full_unstemmed The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia
title_short The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia
title_sort role of a noninvasive index ‘spo2/ fio2’ in predicting mortality among patients with covid-19 pneumonia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044731/
https://www.ncbi.nlm.nih.gov/pubmed/35525158
http://dx.doi.org/10.1016/j.ajem.2022.04.036
work_keys_str_mv AT saticimerveosoydan theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT islammehmetmuzaffer theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT saticicelal theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT uyguncemrenur theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT ademogluenis theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT altunokibrahim theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT akselgokhan theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT erogluserkanemre theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT saticimerveosoydan roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT islammehmetmuzaffer roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT saticicelal roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT uyguncemrenur roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT ademogluenis roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT altunokibrahim roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT akselgokhan roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia
AT erogluserkanemre roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia